Kristina Striepe



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

RELATION BETWEEN NOISE ANNOYANCE, STRESS HORMONES AND THE RENAL HEMODYNAMIC (2021) Bosch A, Kannenkeril D, Rauh M, Ott C, Striepe K, Jung S, Kolwelter J, Schmieder R Conference contribution Detection of Changes in Renal Blood Flow Using Arterial Spin Labeling MRI (2021) Kannenkeril D, Janka RM, Bosch A, Jung S, Kolwelter J, Striepe K, Ott C, et al. Journal article Dependency of flow-mediated vasodilatation from basal nitric oxide activity (2021) Kannenkeril D, Bosch A, Kolwelter J, Jung S, Striepe K, Ott C, Delles C, Schmieder R Journal article Renal and intraglomerular haemodynamics in chronic heart failure with preserved and reduced ejection fraction (2021) Jung S, Bosch A, Kolwelter J, Striepe K, Kannenkeril D, Schuster T, Ott C, et al. Journal article Combination of empagliflozin and linagliptin improves blood pressure and vascular function in type 2 diabetes (2020) Jung S, Bosch A, Kannenkeril D, Karg MV, Striepe K, Bramlage P, Ott C, et al. Journal article Hypertension and kidney disease Bluthochdruck und Nierenerkrankungen (2020) Striepe K, Schmieder R Journal article Combined therapy of empagliflozin and linagliptin is superior to metformin and insulin glargine in improving blood pressure and vascular function in type 2 diabetes (2019) Jung S, Bosch A, Kannenkeril D, Karg M, Striepe K, Bramlage P, Ott C, Schmieder R Conference contribution Tissue sodium concentration emerged as a determinant of hypertrophic vascular remodeling in type 2 diabetes (2019) Schmieder R, Jung S, Kannenkeril D, Harazny JM, Striepe K, Ott C, Linz P, et al. Conference contribution Tissue sodium concentration correlates with hypertrophic vascular remodelling in type 2 diabetes (2019) Kannenkeril D, Jung S, Harazny J, Striepe K, Ott C, Linz P, Nagel AM, et al. Conference contribution Pleiotropic effects under combined therapy with empagliflozin and linagliptin compared to metformin and insulin glargine in patients with type 2 diabetes (2019) Jung S, Ott C, Kannenkeril D, Bosch A, Karg M, Striepe K, Bramlage P, Schmieder R Conference contribution
1 2 3 4 5 6